Blue Sail Medical Announces Tentative Selection of Its Product in National Coronary Drug-Coated Balloon Volume-Based Procurement

Source: Cailian Press

【Bluesail Medical【The Company's Products Are Proposed to Be Selected in the National Coronary Drug-Coated Balloon Bulk Procurement】According to a report by Cailian Press on January 14, Bluesail Medical (002382.SZ) announced that its controlling subsidiary, Jw Medical Systems Limited, participated in the national coronary drug-coated balloon bulk procurement submission and its products are proposed to be selected. If the procurement agreement is subsequently signed and implemented, it is expected to enhance the market influence of the company’s drug-coated balloon products and contribute to the continuous development of the company’s cardiovascular business. However, the selection results are currently being公示, the final results have not been announced, and the procurement agreement has not yet been signed, so the impact on the company’s future performance remains uncertain.